基于纳米偏光特性的生物光学探针在乳腺癌检测识别中的应用研究
Research on the Application of Biooptical Probe Based on Nano Polarization in Detection and Recognition of Breast Cancer
DOI: 10.12677/MD.2023.133052, PDF,    科研立项经费支持
作者: 刘 义：临沂市妇幼保健院医学装备科，山东 临沂；王 慧：临沂市妇幼保健院检验科，山东 临沂
关键词: 金纳米棒；偏光特性；乳腺癌；生物光学探针；AuNRs； Polarization Characteristics； Breast Cancer； Biooptical Probes
摘要: 乳腺癌发病率逐年上升，已成为女性最常见的肿瘤之一，严重危及女性的身体健康。随着乳腺癌诊疗技术的发展，迫切需要新的诊断技术以提高诊断效率，延长乳腺癌患者生存期，因此探索一种快速简便准确的肿瘤检测方法显得尤为重要。金纳米棒(AuNRs)因其独特的光学特性以及易于制备修饰等特点，在生物医学领域得到广泛应用。本文总结了乳腺癌(BC)的分子分型和金纳米棒(AuNRs)的合成、表征及修饰情况，并探索了基于偏光特性的金纳米棒–波形蛋白抗体(AuNRs-AntiVimentin)生物光学探针在乳腺癌组织样本检测中的临床应用。生物光学探针易于合成，操作简单，观测效果较好，与传统免疫组化的乳腺癌阳性检出率没有显著差异，这为乳腺癌组织样本的快速检测提供了新的思路和方法。
Abstract: The incidence rate of breast cancer has increased year by year, and has become one of the most common tumors in women, seriously endangering women’s health. With the development of breast cancer diagnosis and treatment technology, new diagnostic technologies are urgently needed to improve the diagnostic efficiency and prolong the survival period of breast cancer patients. There-fore, it is particularly important to explore a fast, simple and accurate tumor detection method. AuNRs have been widely used in the biomedical field due to their unique optical properties and ease of preparation and modification. This paper summarized the molecular typing of breast cancer (BC) and the synthesis, characterization and modification of AuNRs, and explored the clinical appli-cation of AuNRs-AntiVimentin based on polarization characteristics in the detection of breast cancer tissue samples. Biooptical probes are easy to synthesize, simple to operate, and have good observa-tion effect. There is no significant difference between the positive detection rate of breast cancer and that of traditional immunohistochemistry, which provides new ideas and methods for rapid detection of breast cancer tissue samples.
文章引用：刘义, 王慧. 基于纳米偏光特性的生物光学探针在乳腺癌检测识别中的应用研究[J]. 医学诊断, 2023, 13(3): 343-349. https://doi.org/10.12677/MD.2023.133052

参考文献

[1] Riggio, A.I., Varley, K.E. and Welm, A.L. (2021) The Lingering Mysteries of Metastatic Recurrence in Breast Cancer. British Journal of Cancer, 124, 13-26. [Google Scholar] [CrossRef] [PubMed]
[2] Burstein, H.J., Curigliano, G. and Thür-limann, B. (2021) Customizing Local and Systemic Therapies for Women with Early Breast Cancer: The St. Gallen International Consensus Guidelines for Treatment of Early Breast Cancer 2021. Annals of Oncology, 32, 1216-1235. [Google Scholar] [CrossRef] [PubMed]
[3] Condorelli, R. and Vaz-Luis, I. (2018) Managing Side Effects in Adju-vant Endocrine Therapy for Breast Cancer. Expert Review of Anticancer Therapy, 18, 1101-1112. [Google Scholar] [CrossRef] [PubMed]
[4] Omidi, Y., Mobasher, M., Castejon, A.M. and Mahmoudi, M. (2022) Recent Advances in Nanoscale Targeted Therapy of HER2-Positive Breast Cancer. Journal of Drug Targeting, 30, 687-708. [Google Scholar] [CrossRef] 
[5] Malik, J.A., Ahmed, S., Jan, B., et al. (2022) Drugs Repurposed: An Advanced Step towards the Treatment of Breast Cancer and Associated Challenges. Biomedicine & Pharmacotherapy, 145, Article ID: 112375. [Google Scholar] [CrossRef] [PubMed]
[6] Perou, C.M., Sørlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S.X., Lønning, P.E., Børresen-Dale, A.L., Brown, P.O. and Botstein, D. (2000) Molecular Portraits of Human Breast Tumours. Na-ture, 406, 747-752. [Google Scholar] [CrossRef] [PubMed]
[7] Cancer Genome Atlas Network (2012) Comprehensive Molecular Portraits of Human Breast Tumours. Nature, 490, 61-70. [Google Scholar] [CrossRef] [PubMed]
[8] Cheng, F., Shen, Y., Mohanasundaram, P., Lindström, M., Ivaska, J., Ny, T. and Eriksson, J.E. (2016) Vimentin Coordinates Fibroblast Proliferation and Keratinocyte Differentiation in Wound Healing via TGF-β-Slug Signaling. Proceedings of the National Academy of Sciences of the United States of America, 113, E4320-E4327. [Google Scholar] [CrossRef] [PubMed]
[9] Bronte, G., Puccetti, M., Crinò, L. and Bravaccini, S. (2019) Epitheli-al-to-Mesenchymal Transition and EGFR Status in NSCLC: The Role of Vimentin Expression. Annals of Oncology, 30, 339-340. [Google Scholar] [CrossRef] [PubMed]
[10] Michaels, E., Worthington, R.O. and Rusiecki, J. (2023) Breast Cancer: Risk Assessment, Screening, and Primary Prevention. Medical Clinics of North America, 107, 271-284. [Google Scholar] [CrossRef] [PubMed]
[11] Qu, T., Zhao, Y., Chen, Y., Jin, S., Fang, Y., Jin, X., Sun, L. and Ma, Y. (2019) Down-Regulated MAC30 Expression Inhibits Breast Cancer Cell Invasion and EMT by Suppressing Wnt/β-Catenin and PI3K/Akt Signaling Pathways. International Journal of Clinical and Experimental Pathology, 12, 1888-1896.
[12] Katsura, C., Ogunmwonyi, I., Kankam, H.K. and Saha, S. (2022) Breast Cancer: Presentation, Investigation and Management. British Jour-nal of Hospital Medicine, 83, 1-7. [Google Scholar] [CrossRef] [PubMed]
[13] Tarighati, E., Keivan, H. and Mahani, H. (2023) A Review of Prognostic and Predictive Biomarkers in Breast Cancer. Clinical and Experimental Medicine, 23, 1-16. [Google Scholar] [CrossRef] [PubMed]
[14] Su, Y., Hopfinger, N.R., Nguyen, T.D., Pogash, T.J., Santucci-Pereira, J. and Russo, J. (2018) Epigenetic Reprogramming of Epithelial Mesenchymal Transition in Triple Negative Breast Cancer Cells with DNA Methyltransferase and Histone Deacetylase Inhibitors. Journal of Experimental & Clinical Cancer Research, 37, Ar-ticle No. 314. [Google Scholar] [CrossRef] [PubMed]
[15] Kalyane, D., Polaka, S., Vasdev, N. and Tekade, R.K. (2022) CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells. Pharmaceutics, 14, Article 2734. [Google Scholar] [CrossRef] [PubMed]
[16] Saha, K., Agasti, S.S., Kim, C., Li, X. and Rotello, V.M. (2012) Gold Nanoparticles in Chemical and Biological Sensing. Chemical Re-views, 112, 2739-2779. [Google Scholar] [CrossRef] [PubMed]
[17] Al Mannai, A., Al-Ansari, T. and Saoud, K.M. (2022) Quantification of Serum Exosome Biomarkers Using 3D Nanoporous Gold and Spectrophotometry. Sensors, 22, Article 6347. [Google Scholar] [CrossRef] [PubMed]
[18] Yoo, S., Nam, D.H., Singh, T.I., Leem, G. and Lee, S. (2022) Effect of Reducing Agents on the Synthesis of Anisotropic Gold Nanoparticles. Nano Convergence, 9, Article No. 5. [Google Scholar] [CrossRef] [PubMed]
[19] Zhang, H., Chen, Y., Chui, K.K., Zheng, J., Ma, Y., Liu, D., Huang, Z., Lei, D. and Wang, J. (2023) Synthesis of Bitten Gold Nanoparticles with Single-Particle Chiroptical Responses. Small, 19, e2301476. [Google Scholar] [CrossRef] [PubMed]
[20] Samim, M., Prashant, C., Dinda, A., Maitra, A. and Arora, I. (2022) Synthe-sis and Characterization of Gold Nanorods and Their Application for Photothermal Cell Damage [Retraction]. International Journal of Nanomedicine, 17, 5063-5064. [Google Scholar] [CrossRef] 
[21] Mueller, E.N., Alina, T.B., Curry, S.D., Ganguly, S., Cha, J.N. and Goodwin, A.P. (2022) Silica-Coated Gold Nanorods with Hydrophobic Modification Show Both Enhanced Two-Photon Fluorescence and Ultrasound Drug Release. Journal of Materials Chemistry B, 10, 9789-9793. [Google Scholar] [CrossRef] 
[22] Zhang, K. and Shen, X. (2013) Cancer Antigen 125 Detection Using the Plasmon Resonance Scattering Properties of Gold Nanorods. The Analyst, 138, 1828-1834. [Google Scholar] [CrossRef] [PubMed]
[23] Zhang, Q., Zhang, Z., Zhang, H., Wang, H., Tang, Q., Wang, Y., Gao, Q., Liu, J. and Liu, Y. (2023) Development of a Method to Diagnose Endometrial Cancer Based on the AuNRs-AntiVimentin Optical Probe. Cell Biology International, 47, 1281-1288. [Google Scholar] [CrossRef] [PubMed]
[24] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of In-cidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[25] Zhao, L., Du, X., Fang, B., Liu, Q., Yang, H., Li, F., Sheng, Y., Zeng, X., Zhong, H. and Zhao, W. (2022) Direct Investigations of the Electrical Conductivity of Normal and Cancer Breast Cells by Conductive Atomic Force Microscopy. Ultramicroscopy, 237, Article ID: 113531. [Google Scholar] [CrossRef] [PubMed]
[26] Kalyane, D., Polaka, S., Vasdev, N. and Tekade, R.K. (2023) Cancer Cell-Specific and Laser-Activatable NanoSeeds for Targeted Photothermal Ablation of Triple-Negative Breast Cancer. Photo-chemistry and Photobiology, 99, 1157-1171. [Google Scholar] [CrossRef] [PubMed]
[27] Shao, W., Li, J., Piao, Q., Yao, X., Li, M., Wang, S., Song, Z., Sun, Y., Zheng, L., Wang, G., Liu, L., Yu, C., Huang, Y., Bao, Y. and Sun, L. (2023) FRMD3 In-hibits the Growth and Metastasis of Breast Cancer through the Ubiquitination-Mediated Degradation of Vimentin and Subse-quent Impairment of Focal Adhesion. Death & Disease, 14, Article No. 13. [Google Scholar] [CrossRef] [PubMed]